{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Morgantown",
      "state": "WV",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "75634",
      "recalling_firm": "Mylan Pharmaceuticals Inc.",
      "address_1": "781 Chestnut Ridge Rd",
      "address_2": "N/A",
      "postal_code": "26505-2730",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0151-2017",
      "product_description": "Diltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottle (NDC 0378-5220-05), Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA",
      "product_quantity": "51,983 extended release capsules",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: OOS results for known compound.",
      "recall_initiation_date": "20161103",
      "center_classification_date": "20161123",
      "termination_date": "20170801",
      "report_date": "20161130",
      "code_info": "0378-5220-01 Lot# 3065133; Exp. 03/17  0378-5220-01 Lot# 3066564; Exp. 05/17  0378-5220-05 Lot# 3066564; Exp. 05/17  0378-5220-01 Lot# 3069645; Exp. 08/17  0378-5220-05 Lot# 3069645; Exp. 08/17"
    }
  ]
}